MedTrace Logo

A Randomized Controlled Trial of the Effectiveness of the Ottawa Influenza Decision Aid

NCT01207557 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2011-10-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether, among healthcare personnel who are undecided about whether to receive influenza vaccine, does use of the OIDA increase or decrease their confidence in their decision to be immunized? Furthermore, does the use of the OIDA affect the intent of the healthcare personnel to be immunized or not immunized?

Conditions

Interventions

BEHAVIORAL

Standard Education Only

50% of non-immunized personnel 4 weeks following start of campaign will be given standard education materials and tested on their confidence with their immunization decision

BEHAVIORAL

Standard Education Plus OIDA

50% of non-immunized personnel 4 weeks following start of campaign will be given standard education materials and tested on their confidence with their immunization decision

Sponsors & Collaborators

  • Bruyère Health Research Institute.

    collaborator OTHER

  • Providence Health & Services

    collaborator OTHER

  • Canadian Center for Vaccinology

    collaborator OTHER

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Anne E. McCarthy, MD · Ottawa Hospital Research Institute

  • Larry W Chambers, PhD(Epi) · Bruyère Health Research Institute.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-03-31
Completion
2010-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01207557 on ClinicalTrials.gov